US Biosecure Act, China Plus One, and Trump’s Tariff War: CDMOs Are Hot Topic, As This Small-Cap Pharma Gains 2.66% on CDMO Expansion
US Biosecure Act, China Plus One, and Trump’s Tariff War: CDMOs Are Hot Topic, As This Small-Cap Pharma Gains 2.66% on CDMO Expansion

US Biosecure Act, China Plus One, and Trump’s Tariff War: CDMOs Are Hot Topic, As This Small-Cap Pharma Gains 2.66% on CDMO Expansion

Regulatory changes, such as the US Biosecure Act, may accelerate growth for CDMO businesses. However, uncertainties remain, especially if Donald Trump returns to power. Trump has criticized India on trade issues, including pharmaceutical tariffs, which could impact domestic pharma strategies.

Abhishek Wani Article rating: 5.0

Regulatory changes, such as the US Biosecure Act, may accelerate growth for CDMO businesses. However, uncertainties remain, especially if Donald Trump returns to power. Trump has criticized India on trade issues, including pharmaceutical tariffs, which could impact domestic pharma strategies.

Pre-Open Session vs Special Pre-Open Session in the Stock Market
Pre-Open Session vs Special Pre-Open Session in the Stock Market

Pre-Open Session vs Special Pre-Open Session in the Stock Market

In the stock market, trading happens throughout the day, but not all trades happen during regular hours.

Kiran Shroff Article rating: 5.0

There are specific sessions, called Pre-Open Sessions and Special Pre-Open Sessions, that occur before the official market hours.

Stocks in Focus: Bangalore-based Small Finance Bank Approved to Sell Its Non-Performing Assets (NPA) and Written-Off Loans, Stock Closed 1.17 Per Cent Lower
Stocks in Focus: Bangalore-based Small Finance Bank Approved to Sell Its Non-Performing Assets (NPA) and Written-Off Loans, Stock Closed 1.17 Per Cent Lower

Stocks in Focus: Bangalore-based Small Finance Bank Approved to Sell Its Non-Performing Assets (NPA) and Written-Off Loans, Stock Closed 1.17 Per Cent Lower

Small Finance Bank Shares in Focus After Approval to Sell Rs 364.51 Crore Micro Banking Loan Pool

Abhishek Wani Article rating: 5.0

Small Finance Bank Shares in Focus After Approval to Sell Rs 364.51 Crore Micro Banking Loan Pool

Solar stock in green after bagging order for the supply of 200MW+ of solar inverters
Solar stock in green after bagging order for the supply of 200MW+ of solar inverters

Solar stock in green after bagging order for the supply of 200MW+ of solar inverters

The company has a market cap of over Rs 300 crore and stock is up by 24 per cent from its 52-week low of Rs 212.20 per share.

Kiran Shroff Article rating: 5.0

The company has a market cap of over Rs 300 crore and stock is up by 24 per cent from its 52-week low of Rs 212.20 per share.

Gold Financier’s Stock Soars 2.51 per cent on Media Report of Bain Capital’s Potential Controlling Stake Acquisition
Gold Financier’s Stock Soars 2.51 per cent on Media Report of Bain Capital’s Potential Controlling Stake Acquisition

Gold Financier’s Stock Soars 2.51 per cent on Media Report of Bain Capital’s Potential Controlling Stake Acquisition

Media Reports Indicate the Deal Follows RBI’s Recent Lifting of Curbs on Asirwad Micro Finance

Abhishek Wani Article rating: 5.0

Media Reports Indicate the Deal Follows RBI’s Recent Lifting of Curbs on Asirwad Micro Finance

RSS
1345678910Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307
View Registration Certificate

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346
View Registration Certificate

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList